02/15
Headlines

AMRI

Investors Are Watching: EMC Corporation (NYSE:EMC), Cliffs Natural Resources Inc. (NYSE:CLF), Sanderson Farms, Inc. (NASDAQ:SAFM), Albany Molecular Research Inc. (NASDAQ:AMRI), PAA

Chris Lewis03 mins

On Oct 28, Spanning Cloud Apps, Inc., the most trusted provider of data backup and recovery for cloud applications, today announced that it has been acquired by EMC Corporation (NYSE:EMC). The company will continue to operate under the Spanning® Cloud Apps brand in Austin, Texas and will be the foundation of EMC’s “born-in-the-cloud” data protection…

Read More

Investors Are Watching : Banco Bradesco (NYSE:BBD), Qlik Technologies (NASDAQ:QLIK), Albany Molecular Research Inc. (NASDAQ:AMRI), CNB Financial Corp. (NASDAQ:CCNE), Credicorp (NYSE:BAP)

Chris Lewis02 mins

Banco Bradesco S.A. (NYSE:BBD) Brazil’s second-largest private-sector lender, beat second-quarter profit estimates by a large margin on Wednesday after managing to incorporate the impact of higher borrowing costs into earnings. Banco Bradesco S.A. (NYSE:BBD)’s stock on 30 July traded at beginning with a price of $15.69and when day-trade ended the stock finally decreased -1.02% to…

Read More
FB Nasdaq FB Facebook

Healthcares Week’s 20% Gainers: Chimerix Inc. (NASDAQ:CMRX), TESARO (NASDAQ:TSRO), Albany Molecular Research (NASDAQ:AMRI), Vanda Pharmaceuticals (NASDAQ:VNDA)

John Bellich02 mins

Chimerix Inc. (NASDAQ:CMRX) shares hit a new high on Thursday with the biotechnology firm continuing to get a boost from its decision to increase a test program for a virus-fighting drug so it can try to save a cruelly ill 7-year-old boy. Chimerix Inc. (NASDAQ:CMRX) stock performance was 2.80% in last session and finished the…

Read More

Biotech Overbought Socks: Xencor Inc. (NASDAQ:XNCR), Albany Molecular Research (NASDAQ:AMRI), Oncothyreon (NASDAQ:ONTY), OXiGENE Inc. (NASDAQ:OXGN)

Jayne Crisman02 mins

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer, announced that it will release fourth quarter and full year 2013 financial results after market close on Wednesday, March 19, 2014. Xencor Inc. (NASDAQ:XNCR) stock performance was -1.58% in last session and…

Read More

Biotech Unusual Volume: OXiGENE Inc (NASDAQ:OXGN), TESARO Inc (NASDAQ:TSRO), Discovery Laboratories (NASDAQ:DSCO), Albany Molecular Research (NASDAQ:AMRI)

Jason Knox02 mins

OXiGENE Inc (NASDAQ:OXGN) on Mar. 11 announced positive results from a randomized Phase 2 clinical trial evaluating Avastin(R) (bevacizumab) with or without ZYBRESTAT(R) (fosbretabulin; CA4P) to treat patients with recurrent ovarian cancer. The study, known as Gynecologic Oncology Group protocol 186I, met its primary endpoint of a statistically significant increase in progression-free survival (p-value less…

Read More
FB Nasdaq FB Facebook

Biotech Stocks Touching New Highs: Clovis Oncology (NASDAQ:CLVS), Vanda Pharmaceuticals (NASDAQ:VNDA), Insys Therapeutics (NASDAQ:INSY), Albany Molecular Research (NASDAQ:AMRI)

Jason Knox02 mins

Clovis Oncology Inc. reported a fourth quarter loss of $0.92 per share after the bell Thursday, compared to the loss of $0.81 per share last year. Clovis Oncology Inc. (NASDAQ:CLVS) stock performance was 1.58% in last session and finished the day at $79.62. Traded volume was 0.00 shares in the last session and the average…

Read More